FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136580602> ?p ?o ?g. }

• W3136580602 endingPage "E524" @default.
• W3136580602 startingPage "E505" @default.
• W3136580602 abstract "Background: Human immunodeficiency virus (HIV)-related distal sensory polyneuropathy (DSP) is the most common HIV-associated sensory neuropathy. The envelope glycoprotein of HIV-1, gp 120, appears to contribute to this painful neuropathy. Two standard treatments for HIV infection/ HIV-related painful DSP (e.g., antiviral therapy [e.g., nucleoside reverse transcriptase inhibitors (NRTI)] opioids) should each be carefully evaluated prior to being utilized to ameliorate the pain of DSP, since they may actually promote nociception. Nucleoside reverse transcriptase inhibitors require activation in the cell via the addition of 3 phosphate groups (by cellular kinases) to their deoxyribose moiety, to form NRTI triphosphates. Subsequently, these deoxynucleotide analogs compete with natural deoxynucleotides for incorporation into the growing viral DNA chain. The incorporation of NRTIs into the viral DNA chain leads to chain termination; since the nucleoside reverse transcriptase inhibitors lack a 3’-hydroxyl group on the deoxyribose moiety (unlike natural deoxynucleotides), so that the next incoming deoxynucleotide cannot form the next 5’-3’ phosphodiester bond needed to extend the DNA chain. Unfortunately, many conventional agents utilized as pharmacologic therapy for neuropathic pain are not effective for providing satisfactory analgesia in painful HIV-related distal sensory polyneuropathy. Although there is no robust data, there does seem to be information which would support the notion of opioids having increased risk of being particularly pronociceptive when being used to treat painful HIV-related neuropathy. It thus appears conceivable that the use of at least certain opioids in efforts to achieve analgesia in patients with painful HIV-related neuropathy may be less than ideal since at least certain opioid analgesics themselves may potentially contribute to “fueling the fire” of HIV enhanced pain hypersensitivity; at least in part via upregulation of specific chemokine receptors (e.g., CXCR4) which seem to be vitally important in promoting HIV-related pain facilitation. The risk benefit ratio of treatment with agents such as NRTIs as well as opioids should be reviewed for specific individual patients, prior to clinicians initiating these agents. Objectives: To raise awareness of the theoretical potential downside that opioids may possess if they are used for the treatment of painful HIV-related neuropathy. Methods: A narrative review of selected literature. Limitations: Hypothetical in nature. Conclusions: Clinicians should consider all aspects of various therapeutic options, carefully weighing the risk/benefit ratios of each potential treatment before initiating opioids for painful HIV-related neuropathy. Key words: Human immunodeficiency virus, acquired immune deficiency syndrome, distal sensory polyneuropathy, pain, glia, neuropathy, opioids, nucleoside reverse transcriptase inhibitors" @default.
• W3136580602 created "2021-03-29" @default.
• W3136580602 creator A5058649092 @default.
• W3136580602 date "2011-12-14" @default.
• W3136580602 modified "2023-10-15" @default.
• W3136580602 title "Treatment Considerations in Painful HIV-Related Neuropathy" @default.
• W3136580602 doi "https://doi.org/10.36076/ppj.2011/14/e505" @default.
• W3136580602 hasPublicationYear "2011" @default.
• W3136580602 type Work @default.
• W3136580602 sameAs 3136580602 @default.
• W3136580602 citedByCount "26" @default.
• W3136580602 countsByYear W31365806022013 @default.
• W3136580602 countsByYear W31365806022014 @default.
• W3136580602 countsByYear W31365806022015 @default.
• W3136580602 countsByYear W31365806022016 @default.
• W3136580602 countsByYear W31365806022017 @default.
• W3136580602 countsByYear W31365806022018 @default.
• W3136580602 countsByYear W31365806022019 @default.
• W3136580602 countsByYear W31365806022020 @default.
• W3136580602 countsByYear W31365806022021 @default.
• W3136580602 countsByYear W31365806022022 @default.
• W3136580602 countsByYear W31365806022023 @default.
• W3136580602 crossrefType "journal-article" @default.
• W3136580602 hasAuthorship W3136580602A5058649092 @default.
• W3136580602 hasBestOaLocation W31365806021 @default.
• W3136580602 hasConcept C104317684 @default.
• W3136580602 hasConcept C142462285 @default.
• W3136580602 hasConcept C156719811 @default.
• W3136580602 hasConcept C159047783 @default.
• W3136580602 hasConcept C24107716 @default.
• W3136580602 hasConcept C2777107010 @default.
• W3136580602 hasConcept C2777709666 @default.
• W3136580602 hasConcept C2909970146 @default.
• W3136580602 hasConcept C2993143319 @default.
• W3136580602 hasConcept C3013748606 @default.
• W3136580602 hasConcept C49105822 @default.
• W3136580602 hasConcept C55493867 @default.
• W3136580602 hasConcept C71924100 @default.
• W3136580602 hasConcept C86803240 @default.
• W3136580602 hasConcept C98274493 @default.
• W3136580602 hasConceptScore W3136580602C104317684 @default.
• W3136580602 hasConceptScore W3136580602C142462285 @default.
• W3136580602 hasConceptScore W3136580602C156719811 @default.
• W3136580602 hasConceptScore W3136580602C159047783 @default.
• W3136580602 hasConceptScore W3136580602C24107716 @default.
• W3136580602 hasConceptScore W3136580602C2777107010 @default.
• W3136580602 hasConceptScore W3136580602C2777709666 @default.
• W3136580602 hasConceptScore W3136580602C2909970146 @default.
• W3136580602 hasConceptScore W3136580602C2993143319 @default.
• W3136580602 hasConceptScore W3136580602C3013748606 @default.
• W3136580602 hasConceptScore W3136580602C49105822 @default.
• W3136580602 hasConceptScore W3136580602C55493867 @default.
• W3136580602 hasConceptScore W3136580602C71924100 @default.
• W3136580602 hasConceptScore W3136580602C86803240 @default.
• W3136580602 hasConceptScore W3136580602C98274493 @default.
• W3136580602 hasIssue "6;12" @default.
• W3136580602 hasLocation W31365806021 @default.
• W3136580602 hasOpenAccess W3136580602 @default.
• W3136580602 hasPrimaryLocation W31365806021 @default.
• W3136580602 hasRelatedWork W1984572812 @default.
• W3136580602 hasRelatedWork W2012938607 @default.
• W3136580602 hasRelatedWork W2026081371 @default.
• W3136580602 hasRelatedWork W2042528212 @default.
• W3136580602 hasRelatedWork W2060157537 @default.
• W3136580602 hasRelatedWork W2083854818 @default.
• W3136580602 hasRelatedWork W2330914362 @default.
• W3136580602 hasRelatedWork W3105012339 @default.
• W3136580602 hasRelatedWork W3114565359 @default.
• W3136580602 hasRelatedWork W4297822604 @default.
• W3136580602 hasVolume "6;14" @default.
• W3136580602 isParatext "false" @default.
• W3136580602 isRetracted "false" @default.
• W3136580602 magId "3136580602" @default.
• W3136580602 workType "article" @default.